Tag: commercial rights

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...

4 Top Pharma Stocks on the TSX of Q2 2018

As investors look ahead to the remainder of 2018, we've put together a list of the top-gaining pharmaceutical stocks on...

Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results

Aeglea BioTherapeutics (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic...

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.

BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Relapsed or Refractory Mature T-and NK-Cell Lymphomas

BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of...

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...